Cargando…

Targeted therapy in the treatment of malignant gliomas

Malignant gliomas are invasive tumors with the potential to progress through current available therapies. These tumors are characterized by a number of abnormalities in molecular signaling that play roles in tumorigenesis, spread, and survival. These pathways are being actively investigated in both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lukas, Rimas V, Boire, Adrienne, Nicholas, M Kelly
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886330/ https://www.ncbi.nlm.nih.gov/pubmed/20616900

Ejemplares similares

Genetically Modified Cellular Therapies for Malignant Gliomas
por: Kilian, Michael, et al.
Publicado: (2021)

Combining molecular targeted agents with radiation therapy for malignant gliomas
por: Scaringi, Claudia, et al.
Publicado: (2013)

Gene therapy for malignant glioma
por: Okura, Hidehiro, et al.
Publicado: (2014)

The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma
por: Abdelwahab, Mohammed G., et al.
Publicado: (2012)

Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
por: Yan, Chengrui, et al.
Publicado: (2019)

Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
por: Wilcox, Jessica A., et al.
Publicado: (2022)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Current available therapies and future directions in the treatment of malignant gliomas
por: Desjardins, Annick, et al.
Publicado: (2009)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Polymeric Nanoparticles for the Treatment of Malignant Gliomas
por: Mahmoud, Basant Salah, et al.
Publicado: (2020)

Autophagy as a Potential Therapy for Malignant Glioma
por: Escamilla-Ramírez, Angel, et al.
Publicado: (2020)

The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
por: Wang, Hongxiang, et al.
Publicado: (2015)

Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Current and Future Gene Therapy for Malignant Gliomas
por: Kanzawa, Takao, et al.
Publicado: (2003)

Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
por: Xu, Tao, et al.
Publicado: (2018)

Site-Specific Considerations on Engineered T Cells for Malignant Gliomas
por: Elmadany, Nirmeen, et al.
Publicado: (2022)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application
por: Nayak, Sonali, et al.
Publicado: (2020)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012)

Current FDA-Approved Therapies for High-Grade Malignant Gliomas
por: Fisher, Jacob P., et al.
Publicado: (2021)

Malignant gliomas: old and new systemic treatment approaches
por: Mesti, Tanja, et al.
Publicado: (2016)

Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment
por: Liu, Ching-Ann, et al.
Publicado: (2018)

Tumor Metabolism of Malignant Gliomas
por: Ru, Peng, et al.
Publicado: (2013)

Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas
por: Fetcko, Kaleigh, et al.
Publicado: (2017)

Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy
por: Landi, Daniel, et al.
Publicado: (2014)

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas
por: Pereira, Mery Stefani Leivas, et al.
Publicado: (2017)

Molecular Interactions in the Development of Brain Metastases
por: Martinez, Nina, et al.
Publicado: (2013)

Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
por: Schmalz, Philip G.R., et al.
Publicado: (2011)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas
por: Caffo, Maria, et al.
Publicado: (2023)

The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
por: Sooreshjani, Moloud, et al.
Publicado: (2023)

MET in glioma: signaling pathways and targeted therapies
por: Cheng, Fangling, et al.
Publicado: (2019)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013)

cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma
por: Tripathi, Shashwat, et al.
Publicado: (2022)

Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
por: Jiang, Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_trt936ihd0pbu9ar2jgpu6kt3t